A Study of AK104+Lenvatinib in Combination With Transarterial Chemoembolization (TACE) Versus TACE in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma

Conditions: Hepatocellular Carcinoma Interventions: Drug: AK104; Drug: Lenvatinib; Procedure: TACE; Other: Placebo for AK104; Other: Placebo for Lenvatinib Sponsors: Akeso Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials